On ECHEMI
Home > Drugs > Anhui Double-Crane Pharmaceutical Co., Ltd.
Anhui Double-Crane Pharmaceutical Co., Ltd.
  • Founded in:

    2000-09-13
  • Country:

    China China
  • Address:

    No. 2 Tiancheng Road, Sanshan Economic Development Zone, Wuhu City, Anhui Province
  • Tax NO.:

    913402081497470308
  • Registered Funds:

    82.6087 million yuan
  • Email:

Related Drugs
Theophylline Sodium Chloride Injection
Name Description Content CAS NO. Registered Holders
Theophylline

No specific description provided

More

No specific description provided

58-55-9 26
Sodium chloride

No specific description provided

More

No specific description provided

7647-14-5 43
Piracetam Sodium Chloride Injection
The main ingredient of this product is piracetam, and its chemical name is: 2-oxido-1-pyrrolidinylacetamide.
Name Description Content CAS NO. Registered Holders
Piracetam

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

More

This product is a brain metabolism improving drug, which is a cyclic derivative of г-aminobutyric acid. It has the effect of resisting brain function damage caused by physical and chemical factors. It can promote the generation of ATP in the brain, promote the synthesis of acetylcholine and enhance the conduction of nerve excitement, and has the effect of promoting brain metabolism. It can resist brain function damage caused by physical and chemical factors. It has an improving effect on retrograde amnesia caused by hypoxia. It can enhance memory and improve learning ability.

7491-74-9 24
Norfloxacin and Glucose Injection
The main ingredients are norfloxacin and glucose
Name Description Content CAS NO. Registered Holders
Norfloxacin

Fluoroquinolone antibiotics have broad-spectrum antibacterial activity, especially against aerobic Gram-negative bacteria. They act on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

Fluoroquinolone antibiotics have broad-spectrum antibacterial activity, especially against aerobic Gram-negative bacteria. They act on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

70458-96-7 34
GLUCOSE

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

This product is a fluoroquinolone antibacterial drug with a broad-spectrum antibacterial effect, especially high antibacterial activity against aerobic Gram-negative bacteria. It has good antibacterial activity against the following bacteria in vitro: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacter species, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. Norfloxacin also has antibacterial activity against multi-drug resistant bacteria in vitro. It also has good antibacterial effects on penicillin-resistant Neisseria gonorrhoeae, Haemophilus influenzae and Moraxella catarrhalis. Norfloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

58367-01-4 15
Glycerol Sodium Chloride Injection
This product is a compound preparation, and its composition is: each bottle (250ml) contains 25g of glycerol and 2.25g of sodium chloride.
Name Description Content CAS NO. Registered Holders
Glycerol

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

25g 56-81-5 61
Sodium chloride

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

2.25g 7647-14-5 43
Granisetron Hydrochloride and Sodium Chloride Injection
Granisetron Hydrochloride
Name Description Content CAS NO. Registered Holders
Granisetron Hydrochloride

This product is a highly selective 5HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. It inhibits the occurrence of nausea and vomiting by antagonizing the 5HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

More

This product is a highly selective 5HT3 receptor antagonist, which has a good preventive and therapeutic effect on nausea and vomiting caused by radiotherapy, chemotherapy and surgery. It inhibits the occurrence of nausea and vomiting by antagonizing the 5HT3 receptors in the central chemoreceptor area and peripheral vagus nerve endings. This product has high selectivity and no side effects such as extrapyramidal reactions and excessive sedation.

107007-99-8 35
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.